Tumors with the highest frequency of E-Cadherin upregulation included various subtypes of testicular germ cell tumors (positive 57 to 100%), melanocytic tumors (40 to 67%), and RCC (positive 42 to 57%). This evidence concerns the gene CDH1 and renal cell adenocarcinoma.